Phase 1 Study of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients
Latest Information Update: 18 Dec 2015
Price :
$35 *
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics; Pharmacokinetics
- 01 Sep 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 09 May 2012 New trial record